US20050226926A1 - Sustained-release tablet composition of pramipexole - Google Patents

Sustained-release tablet composition of pramipexole Download PDF

Info

Publication number
US20050226926A1
US20050226926A1 US10/626,166 US62616603A US2005226926A1 US 20050226926 A1 US20050226926 A1 US 20050226926A1 US 62616603 A US62616603 A US 62616603A US 2005226926 A1 US2005226926 A1 US 2005226926A1
Authority
US
United States
Prior art keywords
composition
tablet
pramipexole
starch
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/626,166
Inventor
Gregory Amidon
Loksidh Ganorkar
John Heimlich
Ernest Lee
Robert Noack
Joseph Reo
Connie Skoug
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US39842702P priority Critical
Priority to US39844702P priority
Priority to US47951303P priority
Application filed by Pfizer Inc filed Critical Pfizer Inc
Priority to US10/626,166 priority patent/US20050226926A1/en
Assigned to PHARMACIA CORPORATION reassignment PHARMACIA CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AMIDON, GREGORY, GANORKAR, LOKSIDH D., HEIMLICH, JOHN M., LEE, ERNEST J., NOACK, ROBERT M, REO, JOSEPH P., SKOUG, CONNIE J.
Publication of US20050226926A1 publication Critical patent/US20050226926A1/en
Assigned to BOEHRINGER INGELHEIM INTERNATIONAL GMBH reassignment BOEHRINGER INGELHEIM INTERNATIONAL GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PHARMACIA CORPORATION
Abandoned legal-status Critical Current

Links